Picture of Pixium Vision SA logo

ALPIX — Pixium Vision SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Pixium Vision: Implantation Of First Patient In Italy In Prima System European Pivotal Trial Primavera

Sept 13 (Reuters) - Pixium Vision SA  ALPIX.PA :
    * PIXIUM VISION ANNOUNCES IMPLANTATION OF FIRST PATIENT IN
ITALY
IN PRIMA SYSTEM EUROPEAN PIVOTAL TRIAL PRIMAVERA
    * PRIMAVERA ON TRACK TO READ-OUT AROUND END OF 2023
    * FOLLOWS SUCCESSFUL IMPLANTATIONS AT CLINICAL SITES IN
FRANCE,
GERMANY, UK AND NETHERLANDS
    * PRIMAVERA ON TRACK TO READ-OUT AROUND END OF 2023
    * STUDY WILL INCLUDE THREE YEARS OF FOLLOW-UP, WITH AN
ASSESSMENT
OF PRIMARY ENDPOINTS AT 12 MONTHS AFTER IMPLANTATION

Source text for Eikon:  ID:nGNEc1vdPt 
Further company coverage:  ALPIX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Pixium Vision SA

See all news